Thyrotropin suppressive therapy in thyroid carcinoma: what are the targets?

Suppr

超能文献

作者信息

Brabant G

机构信息

Department of Endocrinology, Christie Hospital, Wilmslow Road, Manchester M20 4BX, United Kingdom.

出版信息

J Clin Endocrinol Metab. 2008 Apr;93(4):1167-9. doi: 10.1210/jc.2007-2228.

DOI:10.1210/jc.2007-2228

PMID:18390811

Abstract

摘要

相似文献

Thyrotropin suppressive therapy in thyroid carcinoma: what are the targets?

J Clin Endocrinol Metab. 2008 Apr;93(4):1167-9. doi: 10.1210/jc.2007-2228.

Suppressive therapy in the management of metastatic thyroid carcinoma.

Otolaryngol Clin North Am. 1980 Feb;13(1):115-8.

Insights from molecular pathways: potential pharmacologic targets of benign thyroid nodules.

Curr Opin Endocrinol Diabetes Obes. 2007 Oct;14(5):393-7. doi: 10.1097/MED.0b013e3282ef5f96.

Thyrocyte-specific Gq/G11 deficiency impairs thyroid function and prevents goiter development.

J Clin Invest. 2007 Sep;117(9):2399-407. doi: 10.1172/JCI30380.

TSH induces metallothionein 1 in thyrocytes via Gq/11- and PKC-dependent signaling.

J Mol Endocrinol. 2013 Jun 4;51(1):79-90. doi: 10.1530/JME-12-0200. Print 2013.

[Vasoconstrictive action of urotensin II].

Nihon Rinsho. 2004 Sep;62 Suppl 9:709-10.

[Optimal thyroid stimulating hormone suppression in treatment of thyroid cancer: from experience to evidence-base].

Zhonghua Nei Ke Za Zhi. 2014 Sep;53(9):694-6.

Effects of physical activity on body composition and fatigue perception in patients on thyrotropin-suppressive therapy for differentiated thyroid carcinoma.

Thyroid. 2011 Jul;21(7):695-700. doi: 10.1089/thy.2010.0052. Epub 2011 May 26.

Does postoperative thyrotropin suppression therapy truly decrease recurrence in papillary thyroid carcinoma? A randomized controlled trial.

J Clin Endocrinol Metab. 2010 Oct;95(10):4576-83. doi: 10.1210/jc.2010-0161. Epub 2010 Jul 21.

Sphingolipid-cholesterol domains (lipid rafts) in normal human and dog thyroid follicular cells are not involved in thyrotropin receptor signaling.

Endocrinology. 2004 Mar;145(3):1464-72. doi: 10.1210/en.2003-1432. Epub 2003 Dec 11.

引用本文的文献

Tailoring TSH suppression in differentiated thyroid carcinoma: evidence, controversies, and future directions.

Endocrine. 2025 Apr 9. doi: 10.1007/s12020-025-04223-w.

Change in pericardial fat volume in postmenopausal women with papillary thyroid cancer undergoing thyrotropin suppressive therapy.

BMC Endocr Disord. 2025 Jan 8;25(1):6. doi: 10.1186/s12902-024-01800-4.

The necessity of thyroid-stimulating hormone suppression therapy for low-risk differentiated thyroid carcinoma following hemithyroidectomy: A systematic review and meta-analysis.

Heliyon. 2024 Nov 22;10(23):e40574. doi: 10.1016/j.heliyon.2024.e40574. eCollection 2024 Dec 15.

Prognostic Implications of Maintaining the Target Thyroid-Stimulating Hormone Status Based on the 2015 American Thyroid Association Guidelines in Patients with Low-Risk Papillary Thyroid Carcinoma after Lobectomy: A 5-Year Landmark Analysis.

Cancers (Basel). 2024 Sep 24;16(19):3253. doi: 10.3390/cancers16193253.

Levothyroxine Dosing for Thyroid-Stimulating Hormone Suppression in Patients with Differentiated Thyroid Cancer after Total Thyroidectomy.

Endocrinol Metab (Seoul). 2024 Aug;39(4):576-578. doi: 10.3803/EnM.2024.401. Epub 2024 Aug 26.

The Effect of Thyrotropin Suppression on Survival Outcomes in Patients with Differentiated Thyroid Cancer: A Systematic Review and Meta-Analysis.

Thyroid. 2024 Jun;34(6):674-686. doi: 10.1089/thy.2023.0711. Epub 2024 May 14.

A comparative analysis of treatment efficacy in intermediate-risk thyroid cancer.

Eur Arch Otorhinolaryngol. 2023 May;280(5):2525-2533. doi: 10.1007/s00405-023-07832-1. Epub 2023 Jan 18.

Tc-Methylene Diphosphonate Treatment is Safe and Efficacious for Osteoporosis in Postmenopausal Differentiated Thyroid Cancer Patients Undergoing TSH Suppression: A Three-Center Non-Randomized Clinical Study.

Cancer Manag Res. 2022 Mar 5;14:995-1005. doi: 10.2147/CMAR.S354471. eCollection 2022.

Incident atrial fibrillation in patients with differentiated thyroid cancer: a meta-analysis.

Endocr Relat Cancer. 2021 Apr 29;28(5):325-335. doi: 10.1530/ERC-20-0496.

Anaplastic thyroid cancer: How far can we go?

EXCLI J. 2020 Jun 15;19:800-812. doi: 10.17179/excli2020-1302. eCollection 2020.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验